Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases, today announced that David Schenkein, M.D., chief executive officer, is scheduled to present at the Leerink Swann 2013 Global Healthcare Conference on Wednesday, February 13, 2013 at 3:00PM EST at the Waldorf Astoria Hotel in New York City.
